Vivian Corporation launch Juvederm® VOLITE from Allergan in Malta

Date: 26/04/2017 16:52:00




Vivian Corporation launch Juvederm® VOLITE from Allergan in Malta

Juvederm® Volite is the first injectable treatment for improving skin quality



Another addition to Vivian Corporation`s ever growing wellbeing portfolio is Allergan`s Juvederm® VOLITE which was launched on Friday 21st April during a seminar for med aesthetic doctors which also included a live workshop at The Clubhouse, Gianpula.


Juvederm® VOLITE is the first injectable treatment designed to improve skin quality for up to nine months with just one treatment session. Using a patented VYCROSS® technology, Juvederm VOLITE® aims to improve skin smoothness (absence of fine lines), hydration and elasticity.


Dr. Dimitris Sykianakis, Medical Trainer and Juvederm® VOLITE  advisory board member, discussed the details of what skin quality really means and how Juvederm® VOLITE can improve the skin and really make it glow. Dimitris Vrachnos, Business Consultant specialised in the medical aesthetics field, gave some insights about what consumers look out for when talking about good skin including tips on patient consultation. A live injection demonstration gave the audience the opportunity to learn first hand how to inject Juvederm® VOLITE in the face, neck, décolletage and hands.


Global research shows that skin quality is a growing concern for women – 56% of women say the appearance of their skin contributes to their outer beauty. The launch of Juvederm® VOLITE offers a treatment designed to last up to 9 months, taking away the need for multiple treatments.


Allergan Malta Country Lead, Katrine Agius commented that Juvederm® VOLITE will now be available throughout all leading Med Aesthetic clinics on the island.


Juvederm® VOLITE: How it works


Juvederm® VOLITE (containing hyaluronic acid) is injected within the dermis which is a layer of soft tissue below the epidermis. The product can be used to treat the face, neck, décolletage and hands and contains the anaesthetic lidocaine, to make the treatment as comfortable as possible. During a thorough consultation, the aesthetic practitioner will discuss and determine the amount of product required to achieve the patient`s desired results.







  • Nestea and S.Pellegrino Vivian Corporation PR

    Nestlé Malta Limited is pleased to inform that Vivian Corporation is being appointed as its local distributor for the Nestea and San Pellegrino Sparkling Fruit Beverages, this with effect from 1st January 2018.

  • TECNIS® Symfony - A New Beginning for Cataract Patients

    Johnson & Johnson Vision with the support of the Saint James Hospital Eye Clinic have just launched the TECNIS® Symfony intraocular lens here in Malta.

  • La Vie

    Leading the way for sustainable luxury in Malta

  • Paediatrics Unwrapped

    Paediatrics Unwrapped – A Gift of Love and Hope

  • Pfizer’s TRUMENBA® Meningococcal Group B vaccine now in Malta

    Pfizer’s TRUMENBA® to Help Prevent Meningococcal Group B Disease in Adolescents and Adults is now available in Malta